Page last updated: 2024-12-05

4,7-dichloroquinoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID6866
CHEMBL ID319828
SCHEMBL ID317202
MeSH IDM0108325

Synonyms (61)

Synonym
4,7-dichloroquinolinium
BIDD:GT0207
einecs 201-714-7
brn 0125359
tl 1473
ai3-50374
nsc 593
4,7-dichloro-quinoline
CHEMBL319828
quinoline, 4,7-dichloro-
wln: t66 bnj eg ig
86-98-6
nsc593
quinoline,7-dichloro-
nsc-593
4,7-dichloroquinoline ,
4,7-dichloroquinoline, 97%
4,7-dichloroquinoline, >=99%
AC-10930
D1100
AKOS000119603
A841902
4,7-bis(chloranyl)quinoline
4, 7-dichloroquinoline
z61o2heq2j ,
5-20-07-00316 (beilstein handbook reference)
unii-z61o2heq2j
BP-12433
FT-0617285
FT-0617286
1138471-54-1
SCHEMBL317202
AM81211
4,7 dichloroquinoline
4,7dichloroquinoline
4.7-dichloroquinoline
amodiaquine impurity 1
dtxcid7031163
tox21_303863
cas-86-98-6
dtxsid0052590 ,
NCGC00357128-01
Q-200422
STR01070
PS-8247
AC-31966
dichloroquinoline, 4,7-
hydroxychloroquine sulfate impurity g [ep impurity]
mfcd00006774
D77863
4,7-dichloroquinoline; quinoline, 4,7-dichloro-; nsc 593; chloroquine related compound a; hydroxychloroquine sulfate impurity g; hydroxychloroquine impurity g
CS-W020014
F0001-2149
BCP32292
BCP32636
SY001735
Q27295050
SB67463
EN300-20302
HY-59243
Z104477684
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency100.26200.007215.758889.3584AID1224835
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID226297Inhibition of Beta-hematin (hemozoin) formation; No inhibition.2000Journal of medicinal chemistry, Jan-27, Volume: 43, Issue:2
Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of beta-hematin formation, and antiplasmodial activity.
AID158544In vitro antiplasmodial activity against Plasmodium falciparum D102000Journal of medicinal chemistry, Jan-27, Volume: 43, Issue:2
Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of beta-hematin formation, and antiplasmodial activity.
AID219087Association constant with ferriprotoporphyrin IX.2000Journal of medicinal chemistry, Jan-27, Volume: 43, Issue:2
Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of beta-hematin formation, and antiplasmodial activity.
AID1764407Agonist activity at Gal4-fused human Nurr1 LBD expressed in HEK293T cells co-expressing firefly luciferase assessed as luciferase activity at 300 uM incubated for 12 to 14 hrs by hybrid reporter gene assay2021Journal of medicinal chemistry, 03-11, Volume: 64, Issue:5
Fragment-like Chloroquinolineamines Activate the Orphan Nuclear Receptor Nurr1 and Elucidate Activation Mechanisms.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (30.00)18.7374
1990's1 (10.00)18.2507
2000's2 (20.00)29.6817
2010's3 (30.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.37 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index44.00 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (10.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]